Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation American Tower Corporation AMT CoreSite 100Gbps Platform Upgrade Positions Firm for AIDriven Digital Infrastructure Growth TWOD Two beats estimates by 30 percent with 34 cents EPS but shares barely budge ExxonMobil XOM Upcoming Q1 2026 Earnings to Illuminate Geopolitical Energy Impacts Amid Packed Broad Market Earnings Slate FAME Expands to Six New Chapters Strengthens AI Workforce Training in Manufacturing